1
Clinical Trials associated with Human Induced Pluripotent Stem Cell Derived Natural Killer Cells(Nuwacell Biotechnologies) / Not yet recruitingNot Applicable An Open, Dose Escalation and Extension Platform Trial to Evaluate the Safety, Pharmacological and Preliminary Efficacy of Human Induced Pluripotent Stem Cell Derived Natural Killer Cells (iNK) in Chinese Subjects With Solid Tumor
This trial is to investigate the safety, efficacy of iNK in subjects with solid tumor. It is a dose escalation and extension trial.
100 Clinical Results associated with Human Induced Pluripotent Stem Cell Derived Natural Killer Cells(Nuwacell Biotechnologies)
100 Translational Medicine associated with Human Induced Pluripotent Stem Cell Derived Natural Killer Cells(Nuwacell Biotechnologies)
100 Patents (Medical) associated with Human Induced Pluripotent Stem Cell Derived Natural Killer Cells(Nuwacell Biotechnologies)
100 Deals associated with Human Induced Pluripotent Stem Cell Derived Natural Killer Cells(Nuwacell Biotechnologies)